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Comparison of the Effect of Kalsitrapine and Metformin as an adjunct therapy 
on infertility treatment in women with PCOS referring to Alavi Hospital in 
Ardebil 
Abstract 
Background: Chronic anovulation is one of the most common causes of 
infertility. In women with PCOS, other factors related to oocyte quality or 
endometrial and nesting disorders may also play a role. Infertile and non-
ovulatory women who tend to become pregnant are candidates for ovulation 
induction. 
Aim: Considering the importance of PCOS syndrome and the importance of 
its treatment, the aim of this clinical trial was to evaluate the effect of 
kalsitrapine and metformin on the treatment of patients with PCOS. 
Methods and material: The study was performed as a clinical trial. A total of 
80 female patients with PCOS who had referred to the obstetrics clinic of 
Alavi Hospital for infertility treatment were randomly selected with personal 
consent and entered the study. 
Results: The mean age of the subjects was 21.5±08.21 years. There was no 
statistically significant difference between the two groups in terms of age of 
patients (P >0.05). The mean age of the subject’s husbends was 31.49±3.7 
years. There was no statistically significant difference between the two groups 
in terms of subject’s husbends age (P >0.05). There was no statistically 
significant difference between the two groups in terms of BMI (P >0.05). 
There was no statistically significant difference between the two groups in 
terms of primary and secondary infertility (P >0.05). The mean duration of 
infertility was 3.68±3.49 years. There was no statistically significant 
difference between the two groups in terms of infertility duration (P >0.05). 
There was no statistically significant difference between the two groups in 
terms of the type of menstrual cycle (P >0.05). The response rate to treatment 
was 17.5% in the metformin group and 10% in the kalsitrapinegroup. There 
was no statistically significant difference between the two groups in terms of 
response to treatment (P >0.05). In comparison, none of the studied factors in 
the two groups was significantly associated with the response to treatment (P 
>0.05). 
Conclusion: The success rate of treatment with metformin as an adjunct in the 
treatment of infertility was 17.5% and this rate was obtained in kalsitrapine10. 
There was no significant difference between the two findings, but the high 
success rate of metformin could indicate that calcitropine, as a new herbal 
medicine, did not have a significant advantage over existing drugs. 
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